Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls

Mathilde Preskou; David Siersbæk Mathiesen; B. Hartmann; Andreas H. Lange; L Winther; Jens Juul Holst; Filip Krag Knop; Asger Bach Lund; Jonatan Ising Bagger

doi:10.1007/s00125-025-06497-1

Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls

Mathilde Preskou, David Siersbæk Mathiesen, B. Hartmann, Andreas H. Lange, L Winther, Jens Juul Holst, Filip Krag Knop, Asger Bach Lund, Jonatan Ising Bagger

Originalsprog	Engelsk
Artikelnummer	LBA 89
Tidsskrift	Diabetologia
Vol/bind	68
Udgave nummer	Suppl 1
Sider (fra-til)	S693
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-025-06497-1
Status	Udgivet - okt. 2025
Begivenhed	61th EASD Annual Meeting: EASD 2025 - Wien, Østrig Varighed: 15 sep. 2025 → 19 sep. 2025

Konference

Konference	61th EASD Annual Meeting: EASD 2025
Land/Område	Østrig
By	Wien
Periode	15/09/2025 → 19/09/2025

Adgang til dokumentet

10.1007/s00125-025-06497-1Licens: Ikke-specificeret

Citationsformater

Preskou, M., Mathiesen, D. S., Hartmann, B., Lange, A. H., Winther, L., Holst, J. J., Knop, F. K., Lund, A. B., & Bagger, J. I. (2025). Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls. Diabetologia, 68(Suppl 1), S693. Artikel LBA 89. https://doi.org/10.1007/s00125-025-06497-1

Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls. / Preskou, Mathilde; Mathiesen, David Siersbæk; Hartmann, B. et al.
I: Diabetologia, Bind 68, Nr. Suppl 1, LBA 89, 10.2025, s. S693.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{1cdadba8cefb473f8b53cbc7aba4bdf1,

title = "Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls",

author = "Mathilde Preskou and Mathiesen, {David Siersb{\ae}k} and B. Hartmann and Lange, {Andreas H.} and L Winther and Holst, {Jens Juul} and Knop, {Filip Krag} and Lund, {Asger Bach} and Bagger, {Jonatan Ising}",

year = "2025",

month = oct,

doi = "10.1007/s00125-025-06497-1",

language = "English",

volume = "68",

pages = "S693",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "Suppl 1",

note = "61th EASD Annual Meeting: EASD 2025, EASD ; Conference date: 15-09-2025 Through 19-09-2025",

}

TY - ABST

T1 - Acute i.v. infusion of the amylin analogue pramlintide does not affect glucagon levels in individuals with type 1 diabetes or in healthy controls

AU - Preskou, Mathilde

AU - Mathiesen, David Siersbæk

AU - Hartmann, B.

AU - Lange, Andreas H.

AU - Winther, L

AU - Holst, Jens Juul

AU - Knop, Filip Krag

AU - Lund, Asger Bach

AU - Bagger, Jonatan Ising

PY - 2025/10

Y1 - 2025/10

U2 - 10.1007/s00125-025-06497-1

DO - 10.1007/s00125-025-06497-1

M3 - Conference abstract in journal

SN - 0012-186X

VL - 68

SP - S693

JO - Diabetologia

JF - Diabetologia

IS - Suppl 1

M1 - LBA 89

T2 - 61th EASD Annual Meeting: EASD 2025

Y2 - 15 September 2025 through 19 September 2025

ER -